About Fonar Corporation
Ticker
info
FONR
Trading on
info
NASDAQ
ISIN
info
US3444374058
Industry
info
Diagnostics & Research
Sector
info
Healthcare
CEO
info
Timothy R. Damadian M.D.
Headquarters
info
110 Marcus Drive, Melville, NY, United States, 11747
Employees
info
535
Website
info
fonar.com
FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company offers an Upright MRI scanner, which allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. It also provides non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with legal and regulatory matters, and development and implementation of practice growth and marketing strategies. In addition, the company owns and operates diagnostic imaging facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1978 and is based in Melville, New York.
Metrics
BasicAdvanced
Market cap
info
$98.4M
P/E ratio
info
12.6
EPS
info
$1.23
Dividend Yield
info
0.00%
Beta
info
0.91
Forward P/E ratio
info
0
EBIDTA
info
$15.9M
Ex dividend date
info
1999-03-18
Price & volume
Market cap
info
$98.4M
Average daily volume
info
0M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
12.6
Forward P/E
info
0
PEG ratio
info
0
Trailing P/E
info
12.6
Price to sales
info
0.94
Price to book
info
0.59
Earnings
EPS
info
$1.23
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$15.9M
Revenues (TTM)
info
$104M
Revenues per share (TTM)
info
$16.57
Technicals
Beta
info
0.91
52-week High
info
$17.62
52-week Low
info
$12.00
50-day moving average
info
$15.51
200-day moving average
info
$14.70
Short ratio
info
4.46
Short %
info
0.75%
Management effectiveness
ROE (TTM)
info
6.74%
ROA (TTM)
info
3.36%
Profit margin
info
7.99%
Gross profit margin
info
$42.9M
Operating margin
info
3.28%
Growth
Quarterly earnings growth (YoY)
info
-10.30%
Quarterly revenue growth (YoY)
info
5.10%
Share stats
Outstanding Shares
info
6.2M
Float
info
5.7M
Insiders %
info
4.62%
Institutions %
info
47.24%
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.11
-
-
Q3 • 24Beat
$0.29
-
-
Q4 • 24Beat
$0.37
-
-
Q1 • 25Beat
$0.17
-
-
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$27.2M
$2.5M
9.23%
Q1 • 25
$27.3M
$0.7M
2.67%
Q2 • 25
0.41%
-70.90%
-71.02%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$215M
$54.7M
25.43%
Q1 • 25
$217M
$56.8M
26.19%
Q2 • 25
0.92%
3.91%
2.96%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$3.1M
$-0.6M
$-1.9M
$2.6M
Q1 • 25
$4.2M
$-0.6M
$-1.5M
$3.6M
Q2 • 25
34.13%
7.38%
-19.92%
39.96%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Fonar Corporation share?
Collapse

Fonar Corporation shares are currently traded for undefined per share.

How many shares does Fonar Corporation have?
Collapse

Fonar Corporation currently has 6.2M shares.

Does Fonar Corporation pay dividends?
Collapse

No, Fonar Corporation doesn't pay dividends.

What is Fonar Corporation 52 week high?
Collapse

Fonar Corporation 52 week high is $17.62.

What is Fonar Corporation 52 week low?
Collapse

Fonar Corporation 52 week low is $12.00.

What is the 200-day moving average of Fonar Corporation?
Collapse

Fonar Corporation 200-day moving average is $14.70.

Who is Fonar Corporation CEO?
Collapse

The CEO of Fonar Corporation is Timothy R. Damadian M.D..

How many employees Fonar Corporation has?
Collapse

Fonar Corporation has 535 employees.

What is the market cap of Fonar Corporation?
Collapse

The market cap of Fonar Corporation is $98.4M.

What is the P/E of Fonar Corporation?
Collapse

The current P/E of Fonar Corporation is 12.6.

What is the EPS of Fonar Corporation?
Collapse

The EPS of Fonar Corporation is $1.23.

What is the PEG Ratio of Fonar Corporation?
Collapse

The PEG Ratio of Fonar Corporation is 0.